Drug application
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULFATE)
Drugs@FDA ANDA 062714 · ALCON PHARMS LTD
Key facts
| Drug name | NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE |
|---|---|
| Active ingredients | DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULFATE |
| Application type | ANDA |
| Application number | 062714 |
| Company | ALCON PHARMS LTD |
| Dosage forms | SOLUTION/DROPS, OPHTHALMIC |
| Strength | EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jul 21, 1986 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.